Results 11 to 20 of about 764,224 (312)

How Useful Is Endoscopic Ultrasound in Differentiating T3/T4a T Stage of Colorectal Cancer: A Prospective Study

open access: yesFrontiers in Oncology, 2022
ObjectiveEndoscopic ultrasound (EUS) is an established method for staging of colorectal cancer. Nevertheless, prior assessments of its T stage accuracy have been limited, particularly ambiguity in assessed T3 and T4a stage. This study was to characterize
Chaoqun Han   +6 more
doaj   +1 more source

Retrospective analysis of histopathological spectrum of premalignant and malignant colorectal lesions

open access: yesCancer Research, Statistics, and Treatment, 2021
Background: Colorectal cancers (CRCs) arise due to the progression of acquired or hereditary premalignant lesions. Therefore, an early diagnosis is essential to devise suitable preventive strategies against CRC.
Puja Bhavesh Jarwani   +3 more
doaj   +1 more source

Colorectal Cancer [PDF]

open access: yes, 2021
Psychological issues around colorectal cancer (CRC) can emerge from the point CRC is suspected, through treatment, to living with or beyond cancer. One-third of patients report high levels of anxiety while undergoing investigations for suspected cancer, and emotional difficulties, particularly anxiety and fear of recurrence, can persist for years ...
Miles, Anne, Redeker, Claudia
openaire   +1 more source

Colorectal cancer [PDF]

open access: yesBMJ, 2013
This is the final version of the article. Available from the publisher via the DOI in this record. ; This is one of a series of occasional articles highlighting conditions that may be more common than many doctors realise or may be missed at first presentation.
Hamilton, W, Coleman, MG, Rubin, G
openaire   +3 more sources

Twenty-four Hours Stay After Colorectal Surgery; A Systematic Review

open access: yesJournal of Coloproctology, 2023
Introduction The introduction of Enhanced Recovery After Surgery led to increasing twenty-four hours discharge pathways, for example in laparoscopic cholecystectomy and bariatric surgery.
Bo P. Smalbroek   +7 more
doaj   +1 more source

FIRST LINE 5-FU-BASED CHEMOTHERAPY WITH/WITHOUT BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER: TISSUE BIOMARKER CANDIDATES [PDF]

open access: yesJournal of IMAB, 2016
Purpose: Colorectal cancer is the second leading cause of cancer mortality in the USA. According to Bulgarian National Statistics Institute, 2370 colon and 1664 rectal cancer cases were diagnosed in 2012 with total number of patients 29995.
Assia Konsoulova   +8 more
doaj   +1 more source

COLORECTAL CARCINOGENESIS

open access: yesFUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2001
Colorectal carcinogenesis is a multi-step process during which genetic and epigenetic events determine the transition from a normal cell to a malignant cell. In the past decade, intensive research led to the identification of two types of colorectal cancers that are distinct by their carcinogenesis process.
T, Fukushima, S, Takenoshita
openaire   +3 more sources

Intensified surveillance after surgery for colorectal cancer significantly improves survival

open access: yesEuropean Journal of Medical Research, 2010
Background Postoperative surveillance after curative resection for colorectal cancer has been demostrated to improve survival. It remains unknown however, whether intensified surveillance provides a significant benefit regarding outcome and survival ...
Laubert T   +7 more
doaj   +1 more source

The use of a vascularized pedicle jejunal graft as a treatment for anastomosis dehiscence after transanal pull‐through, with a combined approach, in two dogs

open access: yesClinical Case Reports, 2021
A pedicled jejunal graft was successfully used to treat a colorectal anastomotic dehiscence, which eliminated the tension on the anastomotic site.
Ilaria Falerno   +4 more
doaj   +1 more source

Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer–the Experience of a Tertiary Cancer Center

open access: yesFrontiers in Pharmacology, 2021
Background: Colorectal cancer (CRC) is the third most common cancer in Europe, with an annual increase in incidence ranging between 0.4 and 3.6% in various countries.
Călin Căinap   +26 more
doaj   +1 more source

Home - About - Disclaimer - Privacy